PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis

Background: Gastric cancer (GC) is one of the most common cancers, and it is the third most common cause of cancer-related mortality worldwide. Fluorouracil (5-FU)-based chemotherapy is frequently used for the treatment of advanced GC. However, a substantial proportion of patients eventually experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaohui, Guo, Jiaojiao, Dai, Meng, Wang, Tengqi, Yang, Tingting, Xiao, Xuejun, Tang, Qi, Zhang, Lingli, Jia, Lizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150456/
https://www.ncbi.nlm.nih.gov/pubmed/32284742
http://dx.doi.org/10.7150/jca.41828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150456/
https://www.ncbi.nlm.nih.gov/pubmed/32284742
http://dx.doi.org/10.7150/jca.41828

Ejemplares similares